Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akshay N Gupte

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2026
Long-term Sequelae of Pulmonary Tuberculosis: A Narrative ReviewAkshay N Gupte, Alix Boisson-Walsh, Moises A Huaman, et al.
ERJ Open Research|February 3, 2021
Higher interleukin-6 levels and changes in transforming growth factor-β are associated with lung impairment in pulmonary tuberculosisAkshay N Gupte, Sriram Selvaraju, Sanjay Gaikwad, et al.
Plos One|September 14, 2017
Factors associated with pulmonary impairment in HIV-infected South African adultsAkshay N Gupte, Michelle L Wong, Reginah Msandiwa, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2026
Post-Tuberculosis Lung Disease in Treated Extra-Pulmonary TuberculosisEmily McNair, Shahanara Valawalkar, Samyra R Cox, et al.
BMC Infectious Diseases|October 31, 2019
Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in IndiaAkshay N Gupte, Dileep Kadam, Shashikala Sangle, et al.
Open Forum Infectious Diseases|July 15, 2022
Clinical and Immunological Markers of Pulmonary Impairment Among People With HIV in IndiaAnurima Baidya, Shashikala Sangle, Ivan Marbaniang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 8, 2025
A point-of-care prediction tool for recurrent tuberculosisSamyra R Cox, Aye Hnin Moe, Akshay N Gupte, et al.
Trials|August 5, 2022
Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contactsSamyra R Cox, Abhay Kadam, Sachin Atre, et al.
The Lancet. Global Health|July 2, 2026
Phone-based screening versus home-based screening after tuberculosis in India (TB Aftermath): a multicentre, open-label, randomised, controlled, non-inferiority trialSamyra R Cox, Abhay Kadam, Shahanara Valawalkar, et al.
Thorax|December 2, 2021
Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studiesKatarina Kamenar, Shakir Hossen, Akshay N Gupte, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2026
Long-term Sequelae of Pulmonary Tuberculosis: A Narrative ReviewAkshay N Gupte, Alix Boisson-Walsh, Moises A Huaman, et al.
ERJ Open Research|February 3, 2021
Higher interleukin-6 levels and changes in transforming growth factor-β are associated with lung impairment in pulmonary tuberculosisAkshay N Gupte, Sriram Selvaraju, Sanjay Gaikwad, et al.
Plos One|September 14, 2017
Factors associated with pulmonary impairment in HIV-infected South African adultsAkshay N Gupte, Michelle L Wong, Reginah Msandiwa, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2026
Post-Tuberculosis Lung Disease in Treated Extra-Pulmonary TuberculosisEmily McNair, Shahanara Valawalkar, Samyra R Cox, et al.
BMC Infectious Diseases|October 31, 2019
Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in IndiaAkshay N Gupte, Dileep Kadam, Shashikala Sangle, et al.
Open Forum Infectious Diseases|July 15, 2022
Clinical and Immunological Markers of Pulmonary Impairment Among People With HIV in IndiaAnurima Baidya, Shashikala Sangle, Ivan Marbaniang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 8, 2025
A point-of-care prediction tool for recurrent tuberculosisSamyra R Cox, Aye Hnin Moe, Akshay N Gupte, et al.
Trials|August 5, 2022
Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contactsSamyra R Cox, Abhay Kadam, Sachin Atre, et al.
The Lancet. Global Health|July 2, 2026
Phone-based screening versus home-based screening after tuberculosis in India (TB Aftermath): a multicentre, open-label, randomised, controlled, non-inferiority trialSamyra R Cox, Abhay Kadam, Shahanara Valawalkar, et al.
Thorax|December 2, 2021
Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studiesKatarina Kamenar, Shakir Hossen, Akshay N Gupte, et al.
Pageof 3